rss
J Clin Pathol 54:317-320 doi:10.1136/jcp.54.4.317

Should we screen for globin gene mutations in blood samples with mean corpuscular volume (MCV) greater than 80 fL in areas with a high prevalence of thalassaemia?

Table 3

Projected number of pregnancies at risk of Hb H disease

Type MCV 80–85 fL* <80 fL†
*Calculated using values from table 1 and a prevalence rate11 of 82/1800 for (−−SEA) as follows: for deletional Hb H disease, 70 000 births/year × (31/1727 × 82/1800); for non-deletional Hb H disease, 70 000 × (1/1727 × 82/1800).
†Calculated using values from Lau et al,11 where the prevalence rate of the (−SEA) deletion is 82/1800, the prevalence rate of single α gene deletion is 9/1800, and the prevalence rate of single non-deletion α gene mutations is 0/1800: for deletional Hb H, 70 000 × (82/1800 × 9/1800); for non deletional Hb H, 70 000 × (82/1800 × 0/1800).
MCV, mean corpuscular volume.
Deletional 57 16
Non-deletional 2 0

This Article

Latest from JCP Education

Latest from JCP Education

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of JCP.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

  • Latest Pathology jobs

    Latest Pathology jobs